PREVIOUS ISSUES

Volume-IX

, Issue-II

(SPRING 2024)

  1. HOME
  2. PREVIOUS ISSUES

Search Article



01 - Evaluating Poly-Pharmacy and Drug Interactions in Cardiovascular Treatment: A Ca

http://dx.doi.org/10.31703/gpsr.2024(IX-II).01
10.31703/gpsr.2024(IX-II).01      Published : Jun 2024

Abstract

    Drug-drug interactions (DDIs) have a considerable impact on therapeutic response which, in turn, could result in adverse drug reactions (ADRs), or even treatment failure. It was directed at patients with cardiovascular diseases (CVDs) as this patient group is more likely to experience DDIs owing to the complexity and number of their drug treatments. The study, analyzed 108 prescriptions using diff... Details

    Cardiovascular Diseases, Drug-drug Interactions (DDI’s), Poly-pharmacy

    (1) Muhammad Adnan
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (2) Savera Saghir
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (3) Ejaz Ahmed
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (4) Aimen Sahar
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
    (5) Ahmad Jalal Masood
    Graduate, Saulat Institute of Pharmaceutical Sciences & Drug Research, Quaid-I-Azam University, Islamabad, Pakistan.
PDF Fulltext